Clinical Trials Browser

Phase 1/2 × dimethicone × Clear all

NCT02534129 2017-10-06

Topical Use of Difinsa53™ to Prevent Radiation Dermatitis

Phase 1/2 Terminated

13 enrolled 3 charts

Breast Neoplasms, Dermatitis, Radiodermatitis